§ 21-201. Definitions
West's Annotated Code of MarylandHealth--General
MD Code, Health - General, § 21-201
§ 21-201. Definitions
(b) “Counterfeit drug” means a drug that:
(1) Bears, or the container or labeling of which bears, without authorization, the trademark, trade name, imprint, symbol, or any other identifying mark, or any likeness of any of these markings, of a manufacturer, processor, packer, or distributor other than the one who, in fact, manufactured, processed, packed, or distributed the drug; and
(c)(1) “Established name” means, in regard to a drug or an ingredient of a drug:
(2) In applying the provisions of paragraph (1)(ii) of this subsection, if a drug or an ingredient of a drug is recognized in both the United States Pharmacopoeia and National Formulary and in the Homeopathic Pharmacopoeia of the United States under different official titles, the title used in the United States Pharmacopoeia and National Formulary is the established name, unless the drug is labeled and offered for sale as a homeopathic drug, in which event the official title used in the Homeopathic Pharmacopoeia of the United States is the established name.
(d) “New drug” means any drug that:
(e) “Prescription drug” means a drug that, under § 21-220 of this subtitle, may be dispensed only on the prescription of a health practitioner who is authorized by law to prescribe the drug.
Credits
Added as Health-Environmental § 4-201 by Acts 1982, c. 240, § 2, eff. July 1, 1982. Transferred to Health-General § 21-201 by Acts 1987, c. 306, § 2, eff. July 1, 1987. Amended by Acts 1987, c. 306, § 15, eff. July 1, 1987; Acts 1988, c. 6, §§ 1, 11, eff. July 1, 1988.
Formerly Art. 43, §§ 187A, 189B.
MD Code, Health - General, § 21-201, MD HEALTH GEN § 21-201
Current through legislation effective through May 9, 2024, from the 2024 Regular Session of the General Assembly. Some statute sections may be more current, see credits for details.
End of Document |